Author:
Rochigneux Philippe,Schleinitz Nicolas,Ebbo Mikael,Aymonier Marie,Pourroy Bertrand,Boissier Romain,Salas Sébastien,Deville Jean-Laurent
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference13 articles.
1. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015
2. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016
3. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy;Pusztai;Cytokine,2004
4. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis;Ceribelli;Clin Rheumatol,2017
5. A case of docetaxel induced myositis and review of the literature;Perel-Winkler;Case Rep Rheumatol,2015
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献